Yang X, Xiong M, Fu X, Sun X
Bioact Mater. 2023; 31:247-271.
PMID: 37637080
PMC: 10457517.
DOI: 10.1016/j.bioactmat.2023.07.025.
Watanabe M, Buth J, Haney J, Vishlaghi N, Turcios F, Elahi L
Stem Cell Reports. 2022; 17(10):2220-2238.
PMID: 36179695
PMC: 9561534.
DOI: 10.1016/j.stemcr.2022.08.013.
Jazaeri F, Sheibani M, Nezamoleslami S, Moezi L, Dehpour A
Iran J Pharm Res. 2021; 20(2):1-21.
PMID: 34567142
PMC: 8457732.
DOI: 10.22037/ijpr.2020.113362.14254.
Haridhasapavalan K, Raina K, Dey C, Adhikari P, Thummer R
Stem Cell Rev Rep. 2019; 16(1):56-81.
PMID: 31758374
DOI: 10.1007/s12015-019-09931-1.
Kim E, Tae G
Biomater Res. 2016; 20:39.
PMID: 27980804
PMC: 5142385.
DOI: 10.1186/s40824-016-0086-y.
A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells.
Xu Y, Shan W, Li X, Wang B, Liu S, Wang Y
J Hematol Oncol. 2016; 9(1):102.
PMID: 27686241
PMC: 5043527.
DOI: 10.1186/s13045-016-0326-6.
The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.
Hansel M, Davila J, Vosough M, Gramignoli R, Skvorak K, Dorko K
Curr Protoc Toxicol. 2016; 67:14.13.1-14.13.27.
PMID: 26828329
PMC: 4795152.
DOI: 10.1002/0471140856.tx1413s67.
An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
Menon S, Shailendra S, Renda A, Longaker M, Quarto N
Int J Mol Sci. 2016; 17(1).
PMID: 26805822
PMC: 4730380.
DOI: 10.3390/ijms17010141.
Human induced pluripotent stem cells labeled with fluorescent magnetic nanoparticles for targeted imaging and hyperthermia therapy for gastric cancer.
Li C, Ruan J, Yang M, Pan F, Gao G, Qu S
Cancer Biol Med. 2015; 12(3):163-74.
PMID: 26487961
PMC: 4607817.
DOI: 10.7497/j.issn.2095-3941.2015.0040.
Induction of Neural Progenitor-Like Cells from Human Fibroblasts via a Genetic Material-Free Approach.
Mirakhori F, Zeynali B, Rassouli H, Shahbazi E, Hashemizadeh S, Kiani S
PLoS One. 2015; 10(8):e0135479.
PMID: 26266943
PMC: 4534403.
DOI: 10.1371/journal.pone.0135479.
Perspectives of induced pluripotent stem cells for cardiovascular system regeneration.
Csobonyeiova M, Polak S, Danisovic L
Exp Biol Med (Maywood). 2015; 240(5):549-56.
PMID: 25595188
PMC: 4935267.
DOI: 10.1177/1535370214565976.
Directed differentiation of induced pluripotent stem cells into chondrogenic lineages for articular cartilage treatment.
Lach M, Trzeciak T, Richter M, Pawlicz J, Suchorska W
J Tissue Eng. 2014; 5:2041731414552701.
PMID: 25383175
PMC: 4221915.
DOI: 10.1177/2041731414552701.
In vitro neurogenesis: development and functional implications of iPSC technology.
Compagnucci C, Nizzardo M, Corti S, Zanni G, Bertini E
Cell Mol Life Sci. 2013; 71(9):1623-39.
PMID: 24252976
PMC: 11113522.
DOI: 10.1007/s00018-013-1511-1.
Thinking outside the liver: induced pluripotent stem cells for hepatic applications.
Subba Rao M, Sasikala M, Reddy D
World J Gastroenterol. 2013; 19(22):3385-96.
PMID: 23801830
PMC: 3683676.
DOI: 10.3748/wjg.v19.i22.3385.
Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.
Lai W, Ho J, Chan Y, Ng J, Au K, Wong L
PLoS One. 2013; 8(3):e57876.
PMID: 23472116
PMC: 3589485.
DOI: 10.1371/journal.pone.0057876.
Disease-corrected hepatocyte-like cells from familial hypercholesterolemia-induced pluripotent stem cells.
Fattahi F, Asgari S, Pournasr B, Seifinejad A, Totonchi M, Taei A
Mol Biotechnol. 2012; 54(3):863-73.
PMID: 23247991
DOI: 10.1007/s12033-012-9635-3.
Cell Reprogramming, IPS Limitations, and Overcoming Strategies in Dental Bioengineering.
Ibarretxe G, Alvarez A, Canavate M, Hilario E, Aurrekoetxea M, Unda F
Stem Cells Int. 2012; 2012:365932.
PMID: 22690226
PMC: 3368489.
DOI: 10.1155/2012/365932.
Converted neural cells: induced to a cure?.
Zhang W, Duan S, Li Y, Xu X, Qu J, Zhang W
Protein Cell. 2012; 3(2):91-7.
PMID: 22410787
PMC: 4104580.
DOI: 10.1007/s13238-012-2029-2.
Non-genetic modulation of Notch activity by artificial delivery of Notch intracellular domain into neural stem cells.
Haupt S, Borghese L, Brustle O, Edenhofer F
Stem Cell Rev Rep. 2012; 8(3):672-84.
PMID: 22290418
DOI: 10.1007/s12015-011-9335-6.
Induced pluripotent stem cells and personalized medicine: current progress and future perspectives.
Chun Y, Byun K, Lee B
Anat Cell Biol. 2012; 44(4):245-55.
PMID: 22254153
PMC: 3254878.
DOI: 10.5115/acb.2011.44.4.245.